Pregnancy and Lactation Labeling Rule (PLLR): Implications for Clinical Practice
This webinar will start at 10:00 am Central on April 18, 2017. Before joining, be sure to check system requirements to avoid any connection issues.
Pregnancy and Lactation Labeling Rule (PLLR): Implications for Clinical Practice will review the changes in labeling due to the PLLR, and current implementation strategies and timelines. Clinicians will review what this means for day-to-day practice and present a variety of strategies for patient engagement and education. Information on current surveillance efforts to determine medication safety in the pregnancy/lactation period will be provided.
Target Audience
- Allergist/immunologists
- Obstetricians/gynecologists
- Nurse practitioners
- Pharmacists
- Primary care physicians
- Allied health professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe how the PLLR provides improved information on drug safety data for pregnant and lactating women
- Identify three strategies clinicians can use in their day-to-day practice to inform their pregnant and lactating patients about the PLLR
- Describe one method for evaluating the safety of medications during pregnancy and the lactation period
Planning Committee
Michael Schatz, MD MS FAAAAI
Kaiser Permanente, San Diego, CA
Relevant relationships: GSK: Advisory Board; AstraZeneca/Medimmune, GSK, Merck: Research Grant
Allen Mitchell, MD
Slone Epidemiology Center, Boston, MA
Relevant relationships: None
Kenneth Lyons Jones, MD
University of California - San Diego, San Diego, CA
Relevant relationships: None
Carla Van Bennekom, MPH
Slone Epidemiology Center, Boston, MA
Relevant relationships: None
Leyla Sahin, MD
Food and Drug Admininstration, Silver Spring, MD
Relevant relationships: None
Alison Bryant Mantha, MD
Massachusetts General Hospital, Boston, MA
Relevant relationships: None
Christina Chambers, PhD MPH
University of California School of Medicine, San Diego, CA
Relevant relationships: Amgen, Apotex Inc./Barr Labs Inc., Celegene, GSK, Hoffman La Roche, Janssen Biotche Inc. Pfizer, Sanofi, Takeda, Genzyme: Research Grant
Faculty
Michael Schatz, MD MS FAAAAI
Kaiser Permanente, San Diego, CA
Relevant relationships: GSK: Advisory Board; AstraZeneca/Medimmune, GSK, Merck: Research Grant
Alison Bryant Mantha, MD
Massachusetts General Hospital, Boston, MA
Relevant relationships: None
Christina Chambers, PhD MPH
University of California School of Medicine, San Diego, CA
Relevant relationships: Amgen, Apotex Inc./Barr Labs Inc., Celegene, GSK, Hoffman La Roche, Janssen Biotche Inc. Pfizer, Sanofi, Takeda, Genzyme: Research Grant
Leyla Sahin, MD
Food and Drug Admininstration, Silver Spring, MD
Relevant relationships: None
CME/MOC Reviewers
Anne Ditto, MD FAAAAI
Northwestern University Feinberg School of Medicine, Chicago, IL
Relevant relationships: None
Sara Lowe, NP
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None
Available Credit
- 1.00 CECE credit.
- 1.00 CMECME credit.